Attention to Pricing Issues Pressures Valeant
publication date: Oct 6, 2015
Along with the biotech industry as a whole, Valeant Pharmaceuticals has been the subject of negative publicity lately, and its shares have paid the price.
To gain access to the members only content, click here to subscribe. You will be given immediate access to premium content on the site.